The results see more suggest that the timing and speed of migratory behaviour primarily
reflect physiological constraints. Given the duration of residency of these species in estuaries, this study indicates that estuaries are critical transitional habitats for diadromous fishes during their migration from marine to freshwater habitats.”
“The focus of this research is the study of the microstructures and miscibility at the interface between semi-crystalline and amorphous PLAs [poly (L-lactic acid)(PLLA) with poly (L,D-lactic acid)(PDLLA), respectively]. The blends are prepared through thermal processing (extrusion and hot-pressing). To increase the area of interface between PDLLA and PLLA, the fibers from PLLA and PDLLA are used. Thermal and microstructures of the blends were studied by differential scanning calorimetry (DSC), polarized optical microscopy (POM), dynamic thermogravimetric analysis(DMA), small-angle X-ray diffraction(SAXS) selleck chemical and wide-angle X-ray diffraction (WAXD). The two PLAs are miscible in molten state. However, phase separation is detected after various thermal treatments, with PDLLA being excluded from the regions of interlamellar PLLA regions when PDLLA content is low, as determined from X-ray diffraction studies. The compatibility between the two PLAs is not perfect in the molten state, since enthalpies of the various blends at T-g are
lower than any pure PLA material. The semi-crystalline PLLA fiber can recrystallize alone in the molten amorphous PDLLA, and a higher nuclei density is observed at the interface. (C) 2014 Wiley Periodicals, Inc.”
“A phenyethylamine derivative, 2-amino-N-ethyl-1-phenylbutane (2-AEPB), has recently been detected in doping control and drugs-of-abuse samples, and identified as a non-labelled OICR-9429 price ingredient in a dietary supplement. To facilitate efficient control of this substance we have studied the in vitro metabolic behaviour of 2-AEPB with human liver preparation, compared these results with in vivo pathways in human, and finally propose an analytical strategy to target the potential misuse of 2-AEPB
for toxicological, forensic and doping control purposes. The major in vitro formed metabolites originated from desethylation (M1) and monohydroxylation (M2). A minor metabolite with hydroxylation/N-oxidation was also observed (M3). In vitro-in vivo correlation was studied in an excretion study with a single, oral dose of 2-AEPB-containing supplement. An unmodified substance was the most abundant target compound and detected until the last point of sample collection (72h), and the detection of M1 (40h) and M2 (27h) demonstrated good correlation to in vitro results. In the study with authentic cases (n=6), 2-AEPB and M1 were mainly found in free urinary fraction, whereas higher inter-individual variability was observed for M2.